Viewing Study NCT05061550

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:15 PM
Ignite Modification Date: 2026-01-31 @ 5:53 AM
Study NCT ID: NCT05061550
Status: RECRUITING
Last Update Posted: 2025-12-01
First Post: 2021-09-20
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lung Cancer View
None early-stage View
None Durvalumab View
None Oleclumab View
None Monalizumab View
None AZD0171 View
None Datopotamab Deruxtecan View
None Neoadjuvant View
None Adjuvant View
None Chemotherapy View
None Volrustomig View
None Rilvegostomig View